Healthcare in Action

Value-based care promises better outcomes and lower costs, but making it work in the real world requires more than good intentions. In this episode, Jon Lange speaks with Jay Ackerman, President and CEO of Reveleer, about how fragmented healthcare data, operational friction, and the sheer complexity of the US healthcare system have slowed progress—and how smarter analytics and AI can help unlock the full potential of value-based care. Jay explains how Reveleer turns messy clinical data into actionable insights for payors and providers, helping them improve quality, cost, and outcomes for patients. He also shares lessons on leadership, culture, M&A discipline, and the personal experiences that keep him focused on building a more connected and effective healthcare system.Key TakeawaysReveleer helps payors and providers translate fragmented clinical data into actionable intelligence that supports risk adjustment, quality improvement, and stronger financial performance in value-based care.Providers face major operational complexity, as they often work across fee-for-service and value-based models, while also managing a variety of incentive structures across multiple payors.Reveleer’s Hybrid AI approach uses Gemini alongside a clinical rules engine to surface highly precise insights at the point of care, reducing noise and helping clinicians focus on what matters most.Jay’s approach to M&A is product-led and highly disciplined, with acquisitions focused on filling strategic gaps rather than just adding revenue or customers.Strong leadership in healthcare IT requires constant attention to culture, team, and strategy, along with a deep understanding of real healthcare problems and their real-world impact on patients.

As healthcare IT evolves at a breakneck pace, the right partnerships, technologies, and go-to-market strategies can define success. In this episode, Jon Lange speaks with Joe Schauenberg, Managing Director and Head of Healthcare IT Investment Banking at William Blair, to explore the current healthcare IT landscape and the outlook for continued innovation and investment. Joe shares insights from advising some of the sector’s most transformative companies, discusses how AI is reshaping everything from provider workflows to revenue cycle management, and explains why distribution - and not just product quality - has an outsized impact on success in the market. From mentorship in banking to what makes a compelling M&A story, this episode offers a front-row view of the trends, challenges, and opportunities shaping the future of healthcare IT.Key TakeawaysAI is driving significant impact across provider workflows, revenue cycle, and documentationInvestment bankers play a key advisory role beyond transactions—leveraging objectivity, data, and sector expertise to guide strategic decisions.Mentorship and apprenticeship are critical components of the investment banking business.Growth, AI strategy, and ability to upsell existing customers are key factors that influence buyer interest and deal valuations.

What does it take to reorient a 172-year-old healthcare company toward driving groundbreaking innovations? In this episode, Jon Lange speaks with Brent Saunders, Chairman and CEO of Bausch + Lomb, about how he’s reinvigorating one of the world’s most iconic eye care brands. Brent shares how the company is focused on driving major innovations across its broad portfolio, including Project Halo, a potential breakthrough in contact lens material science that could result in a new paradigm of all-day comfort. Jon and Brent explore what it means to be a great leader in healthcare, the importance of curiosity and humility, and Brent’s personal recipe for happiness. This is a wide-ranging conversation about eye care, leadership, and how to foster a mission-driven culture to ultimately advance the standard of care for patients.Key TakeawaysBausch + Lomb is investing in major innovation across its portfolio, including Project Halo, a potential breakthrough in contact lens material science that could result in a new paradigm of all-day comfort.A new contact lens under development may help slow the progression of myopia in children, which could be a game-changer for pediatric eye care.Revitalizing innovation requires top talent; Brent’s focused on building out his R&D team as a first step toward taking big swings on groundbreaking innovations.Success is a long game; Brent and Jon discuss the myth of “overnight success” and how passion, hard work, and consistency are key ingredients for real success over the long term.

As America’s population ages and the need for care continues to increase, home-based care is rapidly becoming a central pillar of the healthcare system. In this episode, Jon Lange speaks with David Baiada, CEO of Bayada Home Health Care, about how the company has scaled its mission-driven operation to become one of the largest home-based care companies in the U.S. David shares how Bayada’s nonprofit structure, people-first culture, and forward-thinking approach to technology are helping to meet surging demand while preserving compassion at the core of care. With insights on leadership, culture, the future of care delivery, and the importance of listening, this episode offers a powerful vision of healthcare built on purpose and performance.Key Takeaways:Bayada is one of the nation’s largest home-based care providers, delivering services across seven specialties in 24 states and five countries.The organization transitioned from a family-owned company to a nonprofit to ensure long-term mission alignment and sustainability.Workforce shortages pose a major challenge, and the solution will need to be multi-faceted.Bayada takes a rigorous, systems-level approach to culture management, embedding values into hiring, training, recognition, and performance.

As demand for home-based care surges, healthcare providers are under increasing pressure to deliver the right care at the right time with fewer resources. In this episode, Jon Lange speaks with Elliott Wood, CEO of Mosai, about how AI and predictive analytics are transforming home health and hospice care. Newly formed from the merger of Medalogix and Forcura, Mosai offers an intelligent care coordination platform that empowers clinicians with real-time insights to optimize care delivery and outcomes. Jon and Elliott discuss how generative AI and predictive modeling are helping providers improve efficiency, tailor care to each patient’s unique needs, and ultimately drive better outcomes. Elliott also reflects on mission-driven leadership, personal experiences that shaped his approach, and the importance of getting care right, particularly for vulnerable populations.Key Takeaways:Mosai helps providers determine the optimal level of care for home health and hospice patients with AI-powered insights.Predictive models support clinicians in aligning on care plans and adjusting for risk and patient needs.Generative AI is being used to automate clinician research, saving time and enhancing decision-making.The shift to value-based care and reimbursement makes care planning more important than ever.Mission-driven leadership, combined with innovation, is essential to driving better solutions in healthcare and healthcare technology.

Every hospital, pharmacy, clinic, and home delivery relies on something we often take for granted: the quiet but essential machinery of healthcare distribution.  In this episode, Jon Lange speaks with Mike Kaufmann, former CEO of Cardinal Health, about what it takes to lead one of the largest and systemically important healthcare services companies in the world. From building resilient supply chains to navigating COVID-19, Mike shares leadership lessons, behind-the-scenes insights into the distribution sector, and the high-stakes responsibility of delivering life-saving products when every moment counts. Key Takeaways:Cardinal Health plays a critical role in delivering pharmaceuticals and medical supplies across the U.S. and globally.The drug distribution market is dominated by three key players, with Cardinal and its peers evolving through strategic diversification and consolidation.During COVID-19, Cardinal’s leadership team had to navigate the particularly difficult challenge of keeping the company’s 50,000+ employees safe while giving them the support they needed to continue providing essential products and services to providers and patients across the US.Transparent communication, authenticity, and remaining calm under pressure were essential as Cardinal’s leadership navigated through COVID and other crises.Mission-driven leadership is critical in healthcare companies, where daily operations can improve patient care and save lives.

The future of drug development is being reshaped by real world evidence, and TargetRWE is at the center of that transformation. In this episode, Jon Lange sits down with Ed Seguine, CEO of Target RWE and co-founder of Clinical Ink, to unpack how technology, structured data, and clinician insights are accelerating clinical trials and changing how we understand complex diseases. From unlocking the untapped value of messy EMR data to addressing ethical concerns, Ed shares how real world data can reduce trial costs, shorten timelines, and lead to better outcomes for patients. Key Takeaways:Real world evidence (RWE) is becoming essential in designing and supporting clinical trials, particularly for rare and complex diseasesReal world data can help drive efficiency and can even help address ethical concerns, including how to structure clinical trials to make sure patients are getting the benefit of the best data and insights available.AI will increasingly play a critical role in organizing clinical data, improving clinical decision-making without eliminating the need for clinicians

As the U.S. faces an increasing shortage of caregivers, Careforth is showing what’s possible when family caregivers have much-needed support. In this episode, Jon Lange talks with Katie Tardiff, SVP of Clinical Programs and Services at Careforth, about how the company’s structured family caregiving model is helping families care for their loved ones in their homes with personalized care plans and purpose-built technology. Katie shares insights from her clinical work and personal caregiving journey, illustrating how Careforth is transforming both individual lives and the broader home-based care landscape. Key Takeaways:Independent analysis showed Careforth reduced falls by 45% and ER visits by 21% vs. control group.Careforth’s structured family caregiving model enables Medicaid-eligible families to keep loved ones at home with personalized care plans and purpose-built technology.With over 53 million caregivers in the U.S., Careforth is addressing a national workforce gap through home-based, family-led care.

Generative AI has exploded into the healthcare space, but where is it actually creating value, and where is it just noise? In this episode, hosts Jon Lange and Josh Nelson are joined by Grace Wynn and Eric Berger, partners in the healthcare and life sciences practice at Bain & Company. Together, they explore the evolution of generative AI, why it has taken center stage, and how it’s starting to impact health systems, clinicians, payors, and patients alike. From ambient listening to automated claim letters, this episode cuts through the hype to highlight real-world applications (and unintended consequences) of GenAI in healthcare. Key Takeaways:Use cases in healthcare are growing fast, especially in administrative tasks like medical documentation, prior authorization, and patient communications.AI’s impact on clinicians is most promising where it reduces friction without removing human oversight.The payer-provider dynamic is becoming a “bot-on-bot” arms race, with both sides automating increasingly complex workflows.Patients will likely first feel the impact of GenAI through AI-powered chat tools that streamline scheduling, pre-appointment instructions, and multilingual support.

What if your prescription came with an app instead of a pill? In this episode of Healthcare in Action, Jon Lange speaks with Dr. Corey McCann, Managing Partner at T.Rx Capital and the former CEO of Pear Therapeutics, to unpack the promise and the pitfalls of digital therapeutics. From founding Pear to launching T.Rx Capital, Corey has focused on the intersection of biology and technology for over a decade. As a pioneer in the field, Corey shares what it took to create FDA-approved software-based treatments for addiction and insomnia, and why he believes we’re headed toward a future where digital therapeutics can become first-line care. Key Takeaways:How the U.S. behavioral health crisis affects over half the population and the ways digital therapeutics could help bridge the care gap.Greater access, standardization of best practices, and a more favorable side effect profile make digital therapeutics a compelling alternative to in-person therapy and pharmacotherapy.Despite early excitement and innovation, barriers including regulation and reimbursement have held back adoption of digital therapeutics.